Long-term survival and late deaths after allogeneic bone marrow transplantation

Article Abstract:

Bone marrow transplantation can effectively cure some types of leukemia and aplastic anemia, but transplant patients have a higher long-term mortality rate than the general population. Researchers compared 6,691 transplant recipients and a similar group of healthy people. Patients who were free of their disease two years after transplantation had an 89% chance of surviving five additional years, indicating that their diseases were probably cured by the procedure. Over many years, though, transplant patients had a higher risk of death, most commonly from cancer recurrence or graft-versus-host disease, than those in the general population.

France, Patient outcomes, Mortality, Prognosis, Organ transplant recipients, Bone marrow, Bone marrow transplantation, Leukemia, Aplastic anemia

---

Fluconazole prophylaxis against fungal colonization and infectdion in preterm infants

Article Abstract:

Giving premature babies the antifungal drug fluconazole appears to be effective in preventing serious fungal infection, according to a study of 100 premature babies. Premature babies are susceptible to infection by a fungus called Candida, which increases their risk of death.

Care and treatment, Evaluation, Prevention, Infants (Premature), Premature infants, Candidiasis, Fluconazole

---

Similar abstracts:

• Abstracts: Preemptive therapy in immunocompromised hosts. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
• Abstracts: Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. part 2 Bone marrow transplantation in sickle cell anemia - the dilemma of choice
• Abstracts: The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. Association of maternal HIV infection with low birth weight
• Abstracts: Allogenic bone marrow transplantation in multiple myeloma. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.